Frontage Holdings Corporation has appointed Dr. Abdul Mutlib as the President of Frontage Laboratories, Canada. Dr. Mutlib, who will continue to serve as Chief Scientific & Strategy Officer, will oversee operations in Toronto and Vancouver, reporting to Co-Chief Executive Officer Dr. Wentao Zhang. This move is part of Frontage's strategy to expand its service offerings in the Canadian market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.